Advertisement
Screener

Adicet Bio, Inc. (ACET) Operating Leases, Future Minimum Payments, Remainder of Fiscal Year

2.4 / 5 stars · 23/48 Roast Me

Adicet Bio, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year

Adicet Bio, Inc. (ACET) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $1.24 million as of 2023-09-30, per its 10-Q filed 2023-11-08.

Discontinued › Notes › Leases

us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2023-11-08

  • 2023-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.24M.
  • 2023-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.39M.
  • 2023-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $3.60M.
  • 2022-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $995.00K.
Period endOperating Leases, Future Minimum Payments, Remainder of Fiscal Year
2023-09-30$1.24M
10-Q · filed 2023-11-08
2023-06-30$2.39M
10-Q · filed 2023-08-09
2023-03-31$3.60M
10-Q · filed 2023-05-09
2022-09-30$995.00K
10-Q · filed 2022-11-08
2022-06-30$2.12M
10-Q · filed 2022-08-10
2022-03-31$2.58M
10-Q · filed 2022-05-12
2021-09-30$503.00K
10-Q · filed 2021-11-10
2021-06-30$973.00K
10-Q · filed 2021-08-12
2020-09-30$1.02M
10-Q · filed 2020-11-05
2019-09-30$147.00K
10-Q · filed 2019-11-05
2019-06-30$380.00K
10-Q · filed 2019-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Valion Bio, Inc. (VBIO)United States$0.077B
Lifevantage Corp (LFVN)United States$0.078B15.40
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41